ArticleLung India : official organ of Indian Chest Society
Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1.
Article in Lung India : official organ of Indian Chest Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 3 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mediastinal and pleural lipomatosis is a rare but usually benign and asymptomatic disease. Mediastinal lipomatosis is associated with steroid use, obesity, hyperlipidemia, diabetes, or Cushing syndrome. In some cases, it becomes symptomatic manifesting with dyspnea, thoracic pain, coughing, dysphonia, dysphagia, supraventricular tachycardia, or persistent pneumonia. Mediastinal lipomatosis has not been reported in association with myotonic dystrophy type 1 (MD1). In a 65yo male with a long-term history of progressive muscle weakness, hyper-creatine-kinase-emia, bilateral cataract, sleep apnea syndrome, gynecomastia, hepatic steatosis, arterial hypertension, atrioventricular block 1, QTc prolongation, hyperlipidemia, hyperuricemia, and hepatopathy, MD1 was diagnosed upon the clinical presentation and a heterozygous CTG repeat expansion of 1200-1400 repeats in DMPK. Work-up for dyspnea and leg edema revealed heart failure and mediastinal and pleural lipomatosis. Upon standard treatment, heart failure resolved. In conclusion, mediastinal and pleural lipomatosis can be a rare manifestation of MD1 and can manifest with heart failure. In patients with mediastinal lipomatosis, MD1 should be excluded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.